All posts by PIER MARIA FORNASARI

PIER MARIA FORNASARI
2024-11-10

COVID-19 Linked to Long-Term Risk for Autoimmune, Autoinflammatory Disease

Long-term monitoring and management of patients is crucial after COVID-19, considering demographic factors, disease severity, and vaccination status, to mitigate these risks. In a population-based study published in JAMA Dermatology, researchers from the Republic of Korea investigated whether having a history of coronavirus disease 2019 (COVID-19) increased the long-term risk of autoimmune and autoinflammatory connective tissue disorders.

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2024-11-06

Space: A new frontier for exploring stem cell therapy

Stem cells grown in microgravity aboard the International Space Station (ISS) have unique qualities that could one day help accelerate new biotherapies and heal complex disease, two Mayo Clinic researchers say.  The research analysis by Fay Abdul Ghani and Abba Zubair, M.D., Ph.D., published in NPJ Microgravity, finds microgravity can strengthen the regenerative potential of cells. Dr.

Read More

No Comments InRESEARCH
PIER MARIA FORNASARI
2024-11-06

Toward better surgical outcomes in patients undergoing knee replacement surgery

Evidence from a questionnaire administered to postoperative patients could settle an ongoing debate regarding best practices in total knee arthroplasty. When performing knee replacement surgery, also called total knee arthroplasty, doctors traditionally try to align the hip, knee, and ankle in a straight line, forming a neutral alignment, rather than replicating the patient’s original alignment.

Read More

No Comments InUncategorized
PIER MARIA FORNASARI
2024-11-03

Research Shows Cleveland Clinic’s Therapeutic Virtual Yoga Program Can Be Effective for Chronic Low Back Pain

Participants also reported better sleep quality and reduced use of pain medications Cleveland Clinic researchers found that a 12-week therapeutic virtual yoga program for chronic low back pain can be a feasible, safe and effective treatment option. The findings are published in JAMA Network Open. Chronic low back pain is very common — up to 20% of adults worldwide

Read More

No Comments InRESEARCH
PIER MARIA FORNASARI
2024-10-25

18-month data suggest myocarditis complications more common after COVID infection than vaccination

A study today in JAMA suggests that hospitalized patients—primarily previously healthy young men—have considerably fewer cardiovascular sequelae by 18 months if they develop myocarditis after COVID-19 mRNA vaccination than after COVID-19 infection. French researchers mined data from the French National Health Data System on all 4,635 residents aged 12 to 49 years hospitalized for myocarditis, or inflammation of the heart

Read More

No Comments InCovid-19
PIER MARIA FORNASARI
2024-10-25

At-home transcranial direct brain stimulation for depression is safe and effective, according to research from UTHealth Houston, King’s College London, and University of East London

A device that delivers direct stimulation to the brain was found to be a safe and effective means of treating depression at home, according to a new study by researchers at UTHealth Houston; the Institute of Psychiatry, Psychology & Neuroscience at King’s College London; and the University of East London. The research was published in Nature

Read More

No Comments InCLINICAL TRIALS
PIER MARIA FORNASARI
2024-10-25

Semaglutide, popular diabetes and weight-loss drug, may reduce risk of Alzheimer’s disease

Researchers at Case Western Reserve School of Medicine have found that, when compared to seven other anti-diabetic drugs, semaglutide, a popular diabetes and weight-loss drug, may lower the risk of Alzheimer’s disease in people with type 2 diabetes (T2D). Alzheimer’s disease is a brain disorder that slowly destroys memory and thinking skills. According to the Alzheimer’s Association, nearly

Read More

No Comments InAGEING